Key Points
-
Nonsystemic vasculitic neuropathy (NSVN) is typically multifocal or asymmetric, painful, sensory or sensorimotor, lower-limb predominant, and characterized by one or more acute attacks
-
NSVN is usually distal-predominant, but can involve proximal nerves, a phenotype designated radiculoplexus neuropathy (diabetic or nondiabetic)
-
The diagnostic gold standard for NSVN is vessel wall inflammation and damage identified by nerve biopsy; a probable diagnosis is possible if the biopsy findings are suspicious but not pathognomonic
-
We propose a clinical definition and differential diagnosis of a multifocal pattern of neuropathy ('mononeuritis multiplex')
-
NSVN and neuropathy-predominant systemic vasculitis should probably be treated with an immunosuppressive agent in addition to corticosteroids.
Abstract
Nonsystemic vasculitic neuropathy (NSVN) is an under-recognized single-organ vasculitis of peripheral nerves that can only be diagnosed with a nerve biopsy. A Peripheral Nerve Society guideline group published consensus recommendations on the classification, diagnosis and treatment of NSVN in 2010, and new diagnostic criteria for vasculitic neuropathy were developed by the Brighton Collaboration in 2015. In this Review, we provide an update on the classification, diagnosis and treatment of NSVN. NSVN subtypes include Wartenberg migratory sensory neuropathy and postsurgical inflammatory neuropathy. Variants include diabetic radiculoplexus neuropathy and — arguably — neuralgic amyotrophy. NSVN with proximal involvement is sometimes termed nondiabetic lumbosacral radiculoplexus neuropathy. Cutaneous polyarteritis nodosa and other skin–nerve vasculitides overlap with NSVN clinically. Three patterns of involvement in NSVN have been identified: multifocal neuropathy, distal symmetric polyneuropathy, and overlapping multifocal neuropathy (asymmetric polyneuropathy). These patterns lack standard definitions, resulting in inconsistencies between studies. We propose definitions and provide an up-to-date differential diagnosis of multifocal neuropathy. Available evidence suggests that NSVN and neuropathy-predominant systemic vasculitis might be controlled better by treatment with corticosteroids and an immunosuppressive agent than with corticosteroids alone. Treated NSVN rarely spreads to other organs, but 30% of patients experience a relapse. Long-term neurological outcome is favourable, but chronic pain is common.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Jennette, J. C. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1–11 (2013).
Collins, M. P., Arnold, W. D. & Kissel, J. T. The neuropathies of vasculitis. Neurol. Clin. 31, 557–595 (2013).
Dyck, P. J. et al. Nonsystemic vasculitic neuropathy. Brain 110, 843–853 (1987).
Collins, M. P. et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J. Peripher. Nerv. Syst. 15, 176–184 (2010).
Garzoni, L. et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford) 48, 1524–1529 (2009).
Filosto, M. et al. Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy. J. Neurol. Sci. 284, 179–181 (2009).
Talarico, R. et al. Behcet's disease: features of neurological involvement in a dedicated centre in Italy. Clin. Exp. Rheumatol. 30, S69–S72 (2012).
Collins, M. P. & Kissel, J. T. in Neuromuscular Disorders in Clinical Practice (eds Katirji, B., Kaminski, H. J. & Ruff, R. L.) 733–785 (Springer, 2014).
Gwathmey, K. G., Burns, T. M., Collins, M. P. & Dyck, P. J. Vasculitic neuropathies. Lancet Neurol. 13, 67–82 (2014).
Collins, M. P. & Dyck, P. J. B. in Peripheral Nerve Disorders: Pathology and Genetics (eds Vallat, J. & Weis, J.) 175–195 (Wiley Blackwell, 2014).
Dyck, P. J., Norell, J. E. & Dyck, P. J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 53, 2113–2121 (1999).
Kararizou, E., Davaki, P., Karandreas, N., Davou, R. & Vassilopoulos, D. Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J. Rheumatol. 32, 853–858 (2005).
Sugiura, M. et al. Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a comparative study. J. Neurol. Sci. 241, 31–37 (2006).
Vital, C. et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J. Peripher. Nerv. Syst. 11, 20–29 (2006).
Terrier, B. et al. Non-systemic vasculitic neuropathy: presentation, therapeutic management and outcome. Nephron 129 (Suppl. 2), 226 (2015).
Hadden, R. D. et al. Vasculitic peripheral neuropathy: case definition and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine 35, 1567–1578 (2017).
Collins, M. P. & Periquet, M. I. Non-systemic vasculitic neuropathy. Curr. Opin. Neurol. 17, 587–598 (2004).
Collins, M. P. & Periquet, M. I. Isolated vasculitis of the peripheral nervous system. Clin. Exp. Rheumatol. 26 (3 Suppl. 49), S118–S130 (2004).
Agadi, J. B., Raghav, G., Mahadevan, A. & Shankar, S. K. Usefulness of superficial peroneal nerve/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy. J. Clin. Neurosci. 19, 1392–1396 (2012).
Reimann, J., Kornblum, C., Tolksdorf, K., Bruck, W. & van Landeghem, F. K. Myopathy and neuropathy with pipestem capillaries and vascular activated complement deposition. Neurology 77, 401–403 (2011).
Murphy, S. M., Farrell, M. A. & Hennessy, M. J. Postpartum relapsing sensory neuritis responsive to intravenous immunoglobulin. J. Neurol. 256, 2085–2086 (2009).
Ramchandren, S. et al. Peripheral nerve vasculitis presenting as complex regional pain syndrome. J. Clin. Neuromuscul. Dis. 10, 61–64 (2008).
Cassereau, J. et al. Necrotizing vasculitis revealed in a case of multiple mononeuropathy after a 14-year course of spontaneous remissions and relapses. Clin. Neurol. Neurosurg. 114, 290–293 (2012).
Pabón Meneses, R. M. et al. Pseudo-conduction block in nonsystemic vasculitic neuropathy [Spanish]. An. Sist. Sanit. Navar 32, 279–287 (2009).
Restrepo, J. F. et al. Necrotizing lymphocytic vasculitis limited to the peripheral nerves: report of six cases and review. Int. J. Rheumatol. 2009, 368032 (2009).
Yamada, M. et al. A case of nonsystemic vasculitic neuropathy with spondylosis deformans in an 84-year-old woman. Nihon Ronen Igakkai Zasshi 50, 400–403 (in Japanese) (2013).
Kim, J. Y., Kim, D. S., Ku, B. D., Han, H. J. & Koo, H. A case of nonsystemic vasculitic neuropathy presenting with multiple cranial neuropathies. Neurol. India 60, 653–655 (2012).
Otsuka, R. et al. Necrotising vasculitis with conduction block in mononeuropathy multiplex with cold agglutinins. J. Neurol. Neurosurg. Psychiatry 67, 556–557 (1999).
Lozeron, P. et al. Vasculitis neuropathy mimicking lower limb mono-radiculopathy: a study and follow-up of 8 cases. Intern. Emerg. Med. 8, 601–609 (2013).
Uceyler, N., Geng, A., Reiners, K., Toyka, K. V. & Sommer, C. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J. Neurol. 262, 2092–2100 (2015).
Hirahara, T. et al. Gait disturbance due to foot drop is refractory to treatment in nonsystemic vasculitic neuropathy. Eur. Neurol. 71, 180–186 (2014).
Saif, M. W., Ciccone, E. & Grunnet, M. L. A case of vasculitic neuropathy: when early intervention can forestall serious complications. Consultant 39, 3135–3141 (1999).
Quirins, M. et al. Non-systemic vasculitis neuropathy: initial presentation and long-term follow-up of a multicentric cohort of 50 patients. J. Peripher. Nerv. Syst. 20, 215 (2015).
Collins, M. P. et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55, 636–643 (2000).
Bennett, D. L. et al. The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J. Neurol. Neurosurg. Psychiatry 79, 1376–1381 (2008).
Collins, M. P. et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology 61, 623–630 (2003).
Davies, L., Spies, J. M., Pollard, J. D. & McLeod, J. G. Vasculitis confined to peripheral nerves. Brain 119, 1441–1448 (1996).
Murthy, J. M., Sundaram, C. & Meena, A. K. Nonsystemic vasculitic neuropathy. J. Assoc. Physicians India 46, 204–206 (1998).
Morozumi, S. et al. Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J. Neuropathol. Exp. Neurol. 70, 340–348 (2011).
Dyck, P. J., Norell, J. E. & Dyck, P. J. Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain 124, 1197–1207 (2001).
Hoffman, G. S. & Calabrese, L. H. Vasculitis: determinants of disease patterns. Nat. Rev. Rheumatol. 10, 454–462 (2014).
Stork, A. C. et al. Wartenberg's migrant sensory neuritis: a prospective follow-up study. J. Neurol. 257, 1344–1348 (2010).
Matthews, W. B. & Esiri, M. The migrant sensory neuritis of Wartenberg. J. Neurol. Neurosurg. Psychiatry 46, 1–4 (1983).
Laterre, C., Ghilain, S., Tassin, S. & Guerit, J. M. Wartenberg's disseminated sensory neuropathy. Rev. Neurol. (Paris) 144, 358–364 (in French) (1988).
Sobue, G., Nakao, N., Kumazawa, K. & Mitsuma, T. Migrating multiple mononeuritis and nonsystemic angitis. Rinsho Shinkeigaku 29, 1210–1215 (in Japanese) (1989).
Zifko, U. A. & Hahn, A. F. Migrant sensory neuropathy: report of 5 cases and review of the literature. J. Peripher. Nerv. Syst. 2, 244–249 (1997).
Nicolle, M. W., Barron, J. R., Watson, B. V., Hammond, R. R. & Miller, T. A. Wartenberg's migrant sensory neuritis. Muscle Nerve 24, 438–443 (2001).
Staff, N. P. et al. Post-surgical inflammatory neuropathy. Brain 133, 2866–2880 (2010).
Kelkar, P., Masood, M. & Parry, G. J. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 55, 83–88 (2000).
Leedman, P. J., Davis, S. & Harrison, L. C. Diabetic amyotrophy: reassessment of the clinical spectrum. Aust. N. Z. J. Med. 18, 768–773 (1988).
Coppack, S. W. & Watkins, P. J. The natural history of diabetic femoral neuropathy. Q. J. Med. 79, 307–313 (1991).
Bastron, J. A. & Thomas, J. E. Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. Mayo Clin. Proc. 56, 725–732 (1981).
Barohn, R. J., Sahenk, Z., Warmolts, J. R. & Mendell, J. R. The Bruns–Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch. Neurol. 48, 1130–1135 (1991).
Said, G. et al. Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 126, 376–385 (2003).
Said, G., Goulon-Goeau, C., Lacroix, C. & Moulonguet, A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann. Neurol. 35, 559–569 (1994).
Llewelyn, J. G., Thomas, P. K. & King, R. H. Epineurial microvasculitis in proximal diabetic neuropathy. J. Neurol. 245, 159–165 (1998).
Younger, D. S., Rosoklija, G., Hays, A. P., Trojaborg, W. & Latov, N. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 19, 722–727 (1996).
Laughlin, R. S. & Dyck, P. J. Diabetic radiculoplexus neuropathies. Handb. Clin. Neurol. 126, 45–52 (2014).
Dyck, P. J. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43, 817–824 (1993).
Collins, M. P., Periquet-Collins, I., Sahenk, Z. & Kissel, J. T. Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits. Muscle Nerve 42, 62–69 (2010).
Dyck, P. J. et al. The multi-center double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy [abstract]. Neurology 66 (Suppl. 2), A191 (2006).
Garces-Sanchez, M. et al. Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy? Ann. Neurol 69, 1043–1054 (2011).
Stewart, J. D. Diabetic truncal neuropathy: topography of the sensory deficit. Ann. Neurol. 25, 233–238 (1989).
Kikta, D. G., Breuer, A. C. & Wilbourn, A. J. Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings. Ann. Neurol. 11, 80–85 (1982).
Streib, E. W. et al. Diabetic thoracic radiculopathy: electrodiagnostic study. Muscle Nerve 9, 548–553 (1986).
Massey, E. W. Diabetic truncal mononeuropathy: electromyographic evaluation. Acta Diabetol. Lat. 17, 269–272 (1980).
Ellenberg, M. Diabetic truncal mononeuropathy — a new clinical syndrome. Diabetes Care 1, 10–13 (1978).
Fealey, R. D., Low, P. A. & Thomas, J. E. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin. Proc. 64, 617–628 (1989).
Katz, J. S. et al. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve 24, 794–798 (2001).
Massie, R. et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 135, 3074–3088 (2012).
Tsairis, P., Dyck, P. J. & Mulder, D. W. Natural history of brachial plexus neuropathy. Report on 99 patients. Arch. Neurol. 27, 109–117 (1972).
van Alfen, N. & van Engelen, B. G. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 129, 438–450 (2006).
Van Eijk, J. J., Groothuis, J. T. & Van Alfen, N. Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve 53, 337–350 (2016).
Kuhlenbaumer, G. et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat. Genet. 37, 1044–1046 (2005).
Suarez, G. A. et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology 46, 559–561 (1996).
Klein, C. J. et al. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J. Neurol. Neurosurg. Psychiatry 73, 45–50 (2002).
Borrie, P. Cutaneous polyarteritis nodosa. Br. J. Dermatol. 87, 87–95 (1972).
Daoud, M. S., Hutton, K. P. & Gibson, L. E. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br. J. Dermatol. 136, 706–713 (1997).
Morgan, A. J. & Schwartz, R. A. Cutaneous polyarteritis nodosa: a comprehensive review. Int. J. Dermatol. 49, 750–756 (2010).
Nakamura, T. et al. Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria. Arch. Dermatol. Res. 301, 117–121 (2009).
Criado, P. R., Marques, G. F., Morita, T. C. & de Carvalho, J. F. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: report of 22 cases and literature review. Autoimmun. Rev. 15, 558–563 (2016).
Chen, K. R. Cutaneous polyarteritis nodosa: a clinical and histopathological study of 20 cases. J. Dermatol. 16, 429–442 (1989).
Kawakami, T. et al. Treatment for cutaneous arteritis patients with mononeuritis multiplex and elevated C-reactive protein. J. Dermatol. 40, 955–961 (2013).
Buffiere-Morgado, A. et al. Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): blinded histologic assessment of 35 cPAN cases. J. Am. Acad. Dermatol. 73, 1013–1020 (2015).
Diaz-Perez, J. L. & Winkelmann, R. K. in Vasculitis (eds Wolff, K. & Winkelmann, R. K.) 273–284 (Lloyd-Luke, 1980).
Pego, P. M., Camara, I. A., Andrade, J. P. & Costa, J. M. Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa. Auto Immun. Highlights 4, 95–99 (2013).
Lubana, S. S., Singh, N., Sanelli-Russo, S. & Abrudescu, A. Non-systemic vasculitic neuropathy: an enigmatic clinical entity. Am. J. Case Rep. 16, 449–453 (2015).
Jeruc, J. et al. Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: a case report. Folia Neuropathol. 44, 140–143 (2006).
Satoh, J., Yamamoto, T. & Kuroda, Y. Vasculitis confined to the peripheral nerve and skin: a variant of non-systemic vasculitic neuropathy. Eur. J. Neurol. 6, 241–244 (1999).
Lee, J. E., Shun, C. T., Hsieh, S. C. & Hsieh, S. T. Skin denervation in vasculitic neuropathy. Arch. Neurol. 62, 1570–1573 (2005).
Uceyler, N., Devigili, G., Toyka, K. V. & Sommer, C. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathol. 120, 109–116 (2010).
Gurer, G., Erdem, S., Kocaefe, C., Ozguc, M. & Tan, E. Expression of matrix metalloproteinases in vasculitic neuropathy. Rheumatol. Int. 24, 255–259 (2004).
Terrier, B. et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum. 57, 1520–1529 (2007).
Broglio, L. et al. Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy. Muscle Nerve 38, 1272–1279 (2008).
Grehl, H. & Schroder, J. M. Significance of degenerating endoneurial cells in peripheral neuropathy. Acta Neuropathol. 81, 680–685 (1991).
Fujimura, H., Lacroix, C. & Said, G. Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study. Brain 114, 1929–1942 (1991).
Bonetti, B. et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J. Neuroimmunol. 73, 145–154 (1997).
Vrancken, A. F., Notermans, N. C., Jansen, G. H., Wokke, J. H. & Said, G. Progressive idiopathic axonal neuropathy — a comparative clinical and histopathological study with vasculitic neuropathy. J. Neurol. 251, 269–278 (2004).
Schroder, J. M. Proliferation of epineurial capillaries and smooth muscle cells in angiopathic peripheral neuropathy. Acta Neuropathol. 72, 29–37 (1986).
Graham, A. R. & Johnson, P. C. Direct immunofluorescence findings in peripheral nerve from patients with diabetic neuropathy. Ann. Neurol. 17, 450–454 (1985).
Schenone, A. et al. Direct immunofluorescence in sural nerve biopsies. Eur. Neurol. 28, 262–269 (1988).
Mazzeo, A., Aguennouz, M., Messina, C. & Vita, G. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch. Neurol. 61, 1097–1102 (2004).
Engelhardt, A., Lorler, H. & Neundorfer, B. Immunohistochemical findings in vasculitic neuropathies. Acta Neurol. Scand. 87, 318–321 (1993).
Mancardi, G. L. et al. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 38, 848–851 (1988).
Van Rhijn, I., Van den Berg, L. H., Bosboom, W. M., Otten, H. G. & Logtenberg, T. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 123, 2020–2029 (2000).
Adams, C. W., Buk, S. J., Hughes, R. A., Leibowitz, S. & Sinclair, E. Perls' ferrocyanide test for iron in the diagnosis of vasculitic neuropathy. Neuropathol. Appl. Neurobiol. 15, 433–439 (1989).
Scarpini, E. et al. Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture. Brain 113, 659–675 (1990).
Manolov, V., Petrova, I. & Vasilev, V. VEGF levels in diagnosis of vasculitic neuropathy. Clin. Lab. 60, 1573–1577 (2014).
Chia, L. et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain 119, 1091–1098 (1996).
Schweikert, K. et al. Contribution of nerve biopsy to unclassified neuropathy. Eur. Neurol. 57, 86–90 (2007).
Deprez, M., de Groote, C. C., Gollogly, L., Reznik, M. & Martin, J. J. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul. Disord. 10, 92–98 (2000).
Claussen, G. C., Thomas, T. D., Goyne, C., Vazquez, L. G. & Oh, S. J. Diagnostic value of nerve and muscle biopsy in suspected vasculitis cases. J. Clin. Neuromuscul. Dis. 1, 117–123 (2000).
Rappaport, W. D. et al. Clinical utilization and complications of sural nerve biopsy. Am. J. Surg. 166, 252–256 (1993).
Hellmann, D. B., Laing, T. J., Petri, M., Whiting-O'Keefe, Q. & Parry, G. J. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine (Baltimore) 67, 145–153 (1988).
Vrancken, A. F., Gathier, C. S., Cats, E. A., Notermans, N. C. & Collins, M. P. The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy. Eur. J. Neurol. 18, 49–58 (2011).
Garces Sanchez, M., Villanueva-Haba, V. E., Sevilla Mantecon, T., Mayordomo Fernandez, F. & Vilchez Padilla, J. J. Nonsystemic vasculitic neuropathy. Neurologia 17, 616–620 (2002).
Mathew, L., Talbot, K., Love, S., Puvanarajah, S. & Donaghy, M. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM 100, 41–51 (2007).
Devigili, G. et al. Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment. Acta Neuropathol. 122, 343–352 (2011).
Abgrall, S. et al. Localized neurological necrotizing vasculitides. Three cases with isolated mononeuritis multiplex. J. Rheumatol. 28, 631–633 (2001).
Sanada, M., Terada, M., Suzuki, E., Kashiwagi, A. & Yasuda, H. MR angiography for the evaluation of non-systemic vasculitic neuropathy. Acta Radiol. 44, 316–318 (2003).
Dyck, P. J. et al. in Companion to Peripheral Neuropathy: Illustrated Cases and New Developments (eds Dyck, P. J. et al.) 3–23 (Saunders, 2010).
Ito, T., Kijima, M., Watanabe, T., Sakuta, M. & Nishiyama, K. Ultrasonography of the tibial nerve in vasculitic neuropathy. Muscle Nerve 35, 379–382 (2007).
Grimm, A., Decard, B. F., Bischof, A. & Axer, H. Ultrasound of the peripheral nerves in systemic vasculitic neuropathies. J. Neurol. Sci. 347, 44–49 (2014).
Uceyler, N., Schafer, K. A., Mackenrodt, D., Sommer, C. & Mullges, W. High-resolution ultrasonography of the superficial peroneal motor and sural sensory nerves may be a non-invasive approach to the diagnosis of vasculitic neuropathy. Front. Neurol. 7, 48 (2016).
Kissel, J. T., Slivka, A. P., Warmolts, J. R. & Mendell, J. R. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann. Neurol. 18, 251–257 (1985).
Wees, S. J., Sunwoo, I. N. & Oh, S. J. Sural nerve biopsy in systemic necrotizing vasculitis. Am. J. Med. 71, 525–532 (1981).
Moore, P. M. & Fauci, A. S. Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am. J. Med. 71, 517–524 (1981).
Griffin, J. W. Vasculitic neuropathies. Rheum. Dis. Clin. North Am. 27, 751–760 (2001).
Vavra, M. W. & Rubin, D. I. The peripheral neuropathy evaluation in an office-based neurology setting. Semin. Neurol. 31, 102–114 (2011).
Alport, A. R. & Sander, H. W. Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap. Minn.) 18, 13–38 (2012).
Thompson, P. D. & Thomas, P. K. in Peripheral Neuropathy (eds Dyck, P. J. & Thomas, P. K.) 1137–1161 (Elsevier, 2005).
Bouche, P. in Peripheral Nerve Disorders: Pathology and Genetics (eds Vallat, J. & Weis, J.) 1–11 (John Wiley & Sons, 2014).
Nardin, R. A. & Rutkove, S. B. in Handbook of Peripheral Neuropathy (eds Bromberg, M. B. & Gordon Smith, A.) 215–238 (Taylor & Francis, 2005).
Rosenbaum, R. & Rose-Innes, A. in Textbook of Peripheral Neuropathy (ed. Donofrio, P. D.) 245–257 (Demos Medical Publishing, 2012).
Muley, S. A. & Parry, G. J. in Textbook of Peripheral Neuropathy (ed. Donofrio, P. D.) 41–55 (Demos Medical Publishing, 2012).
Preston, D. C. & Shapiro, B. E. (eds) in Electromyography and Neuromuscular Disorders 389–420 (Elsevier, 2005).
Collins, M. P. in Encyclopedia of the Neurological Sciences (eds Daroff, R. B. & Aminoff, M. J.) 94–95 (Academic Press, 2014).
Olney, R. K. AAEM minimonograph #38: neuropathies in connective tissue disease. Muscle Nerve 15, 531–542 (1992).
Bromberg, M. B. & Jaros, L. Symmetry of normal motor and sensory nerve conduction measurements. Muscle Nerve 21, 498–503 (1998).
Buschbacher, R. M., Kumbhare, D. A. & Robinson, L. R. Buschbacher's Manual of Nerve Conduction Studies (Demos Medical Publishing, 2016).
Suppiah, R. et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 50, 2214–2222 (2011).
Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221–232 (2010).
Jones, R. B. et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N. Engl. J. Med. 363, 211–220 (2010).
Pagnoux, C., Guillevin, L., French Vasculitis Study Group & MAINRITSAN investigators. Rituximab or azathioprine maintenance in ANCA-associated vasculitis. N. Engl. J. Med. 372, 386–387 (2015).
Ntatsaki, E. et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53, 2306–2309 (2014).
Yates, M. et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 75, 1583–1594 (2016).
Ribi, C. et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum. 62, 1186–1197 (2010).
Samson, M. et al. Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors. Autoimmun. Rev. 13, 197–205 (2014).
Samson, M. et al. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors. Autoimmun. Rev. 13, 945–953 (2014).
Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162–173 (2015).
Ponte, C. et al. Rasch-built Overall Disability Scale (RODS) for vasculitic neuropathy (VN_RODS): an ongoing project. Nephron 129 (Suppl. 2), 192 (2015).
van Nes, S. I. et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76, 337–345 (2011).
Vanhoutte, E. K. et al. Modifying the Medical Research Council grading system through Rasch analysis. Brain 135, 1639–1649 (2012).
Author information
Authors and Affiliations
Contributions
Both authors researched the data for the article, provided substantial contributions to discussions of its content, wrote the article and undertook review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
FURTHER INFORMATION
Supplementary information
Supplementary information S1 (table)
Prevalence of vasculitis types in unselected series of vasculitic neuropathy (PDF 172 kb)
Supplementary information S2 (table)
Clinicopathologic characteristics of the ten largest cohorts of nonsystemic vasculitic neuropathy (PDF 162 kb)
Supplementary information S3 (table)
New evidence on histopathological factors associated with vasculitic neuropathy (PDF 121 kb)
Supplementary information S4 (table)
Evidence on clinical and laboratory factors associated with vasculitic neuropathy (PDF 163 kb)
Supplementary information S5 (box)
Differential diagnosis of multifocal/asymmetric neuropathy (PDF 148 kb)
Rights and permissions
About this article
Cite this article
Collins, M., Hadden, R. The nonsystemic vasculitic neuropathies. Nat Rev Neurol 13, 302–316 (2017). https://doi.org/10.1038/nrneurol.2017.42
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneurol.2017.42
This article is cited by
-
Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary central nervous system lymphoma: a case report
BMC Neurology (2025)
-
Diabetic neuropathy: cutting-edge research and future directions
Signal Transduction and Targeted Therapy (2025)
-
Vaskulitische Beteiligung der Skelettmuskulatur und des peripheren Nervensystems: Klinische und neuropathologische Perspektive
Zeitschrift für Rheumatologie (2025)
-
Monoclonal Gammopathy-Associated Neuropathy
Current Hematologic Malignancy Reports (2025)
-
Rituximab in non-systemic vasculitic neuropathy: a single-center experience
Journal of Neurology (2024)


